Admelog 100 UNT/ML Injectable Solution
- RxCUI
- 1992169
- RxNorm name
- Admelog 100 UNT/ML Injectable Solution
- Display name
- Admelog 100 UNT/ML Injectable Solution
- Full name
- Admelog 100 UNT/ML Injectable Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 209196 | Admelog | insulin lispro | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADMELOG | INSULIN LISPRO | Sanofi-Aventis U.S. LLC | 0691def8-4a7b-4de3-866f-a280989f47f1 | 2025-06-04 | Warnings, Adverse reactions | 1992169 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0691def8-4a7b-4de3-866f-a280989f47f1 | Admelog 100 UNT/ML Injectable Solution | SY | 14 | These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017 | 20250604 |
| 0691def8-4a7b-4de3-866f-a280989f47f1 | Admelog 100 UNT/ML Injectable Solution | PSN | 14 | These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017 | 20250604 |
| 0691def8-4a7b-4de3-866f-a280989f47f1 | insulin lispro 100 UNT/ML Injectable Solution [Admelog] | SBD | 14 | These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017 | 20250604 |